Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls- Eight years follow-up of IBS patients in primary care

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Faresjö, Åshild ^a   Grodzinsky, Ewa ^a   Hallert, Claes ^a   Timpka, Toomas ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Case control; Co morbidity; Disease worry; Functional gastrointestinal disorder; Gender; Public health problem

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FEMALE; FIBROMYALGIA; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; IRRITABLE COLON; MALE; MIDDLE AGED; MIGRAINE; PREVALENCE; PRIMARY HEALTH CARE; REFERENCE VALUE; REGISTER; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; SEX RATIO; SWEDEN; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CASE-CONTROL STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; FEMALE; FIBROMYALGIA; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; MIGRAINE DISORDERS; ODDS RATIO; PREVALENCE; PRIMARY HEALTH CARE; REFERENCE VALUES; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SWEDEN; TIME FACTORS; YOUNG ADULT;

EID: 84883629614     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-832     Document Type: Article

References (66)

1. Epidemiology of IBS. Choung RS, Locke GR III, Gastroenterol Clin North Am 2011 40 1 10 10.1016/j.gtc.2010.12.006 21333897
2. The burden of IBS: looking at metrics. Spiegel BM, Curr Gastroenterol Rep 2009 11 265 269 10.1007/s11894-009-0039-x 19615301
3. Drossman DA, The functional gastrointestinal disorders. Rome II VA, USA: Degnon associates, Mclean 2 2000
4. Health-related quality of life among persons with irritable bowel syndrome a systematic review. El Serag HB, Olden K, Bjorkman D, Aliment Pharmacol Ther 2002 16 1171 1185 10.1046/j.1365-2036.2002.01290.x 12030961 (Pubitemid 34680762)
5. A population based case-control study of work and psychosocial problems in patients with irritable bowel syndrome-women are more seriously affected than men. Faresjö Å Grodzinsky E, Johansson S, Wallander MA, Timpka T, Åkerlind I, Am J Gastroenterol 2007 102 2 371 379 10.1111/j.1572-0241. 2006.01012.x 17156145 (Pubitemid 46164731)
6. Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behaviour? Herschbach P, Henrich G, von Rad M, Psychosom Med 1999 61 148 153 10204966 (Pubitemid 29168643)
7. Predictors of health care seeking for irritable bowel syndrome and non-ulcer dyspepsia: a critical review of the literature on symptoms and psychological factors. Koloski NA, Talley NJ, Boyce PM, Am J Gastroenterol 2001 96 1340 1349 10.1111/j.1572-0241.2001.03789.x 11374666 (Pubitemid 32455057)
8. Reasons for consultation in irritable bowel syndrome: symptoms and patients characteristics. Kettel J, Jones R, Lydiard S, Br J Gen Pract 1992 42 459 461 1472391
9. Doctor's perceptions of patient's cognitions and complaints in irritable bowel syndrome at an out-patients clinic. Van Dulmen AM, Fennis JEM, Mokkink HGA, Van der Velden HGM, Bleijenberg G, J Psychosom Res 1994 38 581 590 10.1016/0022-3999(94)90055-8 7990066 (Pubitemid 24256716)
10. Irritable bowel syndrome: a little understood organic bowel disease? Talley NJ, Spiller R, Lancet 2002 360 555 564 10.1016/S0140-6736(02)09712-X 12241674 (Pubitemid 35232113)
11. Effects of stressful life events on bowel syndrome compared with subjects without bowel dysfunction. Whitehead WE, Crowell MD, Robinson JC, Heller BR, Schuster MM, Gut 1992 33 825 830 10.1136/gut.33.6.825 1624167
12. Altered rectal perceptions are a biological marker of patients with irritable bowel syndrome. Mertz H, Naliboff B, Munkata J, Niazi N, Mayer EA, Gastroenterology 1995 109 40 52 10.1016/0016-5085(95)90267-8 7797041
13. The combinations of medical treatment plus multicomponent behavioural therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Heymann-Mönnikes I, Arnold R, Florin I, Herda C, Melfsen S, Mönnikes H, Am J Gastroenterol 2000 95 981 994 10763948 (Pubitemid 30196735)
14. A randomized trial of psychotherapy in patients with refractory irritable bowel syndrome. Guthrie E, Creed F, Dawson D, Tomenson B, Br J Psychiatry 1993 163 315 321 10.1192/bjp.163.3.315 8401959 (Pubitemid 23274372)
15. Patients with irritable bowel syndrome in Swedish primary care. Faresjö Å Grodzinsky E, Johansson S, Wallander MA, Foldevi M, Eur J Gen Pract 2006 12 88 90 10.1080/13814780600872937 16945886 (Pubitemid 44644463)
16. Patients with IBS in primary care appear not to be heavy health care utilisers. Faresjö A, Grodzinsky E, Foldevi M, Johansson S, Wallander MA, Aliment Pharmacol Ther 2006 23 6 807 811 10.1111/j.1365-2036.2006.02815.x 16556183 (Pubitemid 43344600)
17. Comorbid conditions in patients with irritable bowel syndrome: data from a national IBS awareness registry. Markowitz M, Harris W, Ricci JF, Harrison C, Gordon SH, Wentz A, Gastroenterology 2001 120 suppl1 105
18. Co-morbidity of fibromyalgia with medical and psychiatric disorders. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L, Am J Med 1992 92 363 367 10.1016/0002-9343(92)90265-D 1558082
19. Irritable bowel -type symptoms in HMO examinees; prevalence, demographics, and clinical correlates. Longstreth GF, Wolde-Tsadik G, Dig Dis Sci 1993 38 1581 1589 10.1007/BF01303163 8359067 (Pubitemid 23271410)
20. Use of the functional bowel disorder severity index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia. Sperber AD, Carmel S, Atzmon Y, Weisberg I, Shalit Y, Neuman L, Fich A, Friger M, Buskila D, Am J Gastroenterol 2000 95 995 998 10.1111/j.1572-0241.2000.01977.x 10763949 (Pubitemid 30196736)
21. Chronic pelvic pain and gynaecological symptoms in women with irritable bowel syndrome. Walker EA, Gelfand AN, Gelfand MD, Green C, Katon WJ, J Psychosom Obstet Gyneacol 1996 17 39 46 10.3109/01674829609025662 (Pubitemid 26144133)
22. The sense of coherence index and the irritable bowel syndrome: a cross-sectional comparison among irritable bowel syndrome patients with and without coexisting fibromyalgia, irritable bowel syndrome non-patients, and controls. Sperber AD, Carmel S, Atzmon Y, Weisberg I, Shalit Y, Neuman L, Fich A, Buskila D, Scand J Gastroenterol 1999 34 259 263 10.1080/00365529950173654 10232869 (Pubitemid 29192996)
23. Psysical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the general practice research database. Jones R, Lationovic J, Charlton J, Gulliford M, Aliment Pharmacol Ther 2006 24 879 886 10.1111/j.1365-2036.2006.03044.x 16918893
24. Prevalence, co morbidity and impact of irritable bowel syndrome in Norway. Vandvik PO, Lydersen S, Farup PG, Scand J Gastroenterol 2006 41 650 656 10.1080/00365520500442542 16716962 (Pubitemid 43995005)
25. The Rome II and Rome III criteria identify the same subtype-populations in irritable bowel syndrome: agreement depends on the method used for symptom report. Engsbro AL, Simrèn M, Bytzer P, Neurogastroenterol Motil 2012 24 604 611 E266 10.1111/j.1365-2982.2012.01908.x 22420629
26. Estimating disease prevalence using a population-based administrative health care database. Wiréhn AB, Karlsson M, Carstensen J, Scand J Public Health 2007 35 424 431 10.1080/14034940701195230 17786807 (Pubitemid 47386793)
27. Systematic review of the co-morbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Whithead WE, Palsson O, Jones KR, Gastroenterology 2002 122 1140 1156 10.1053/gast.2002.32392 11910364 (Pubitemid 34267295)
28. RITMO group: predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients. Mearin F, Badia X, Balboa A, Benavent J, Caballeros AM, Domìnguez-Munoz E, Garrigues V, Pique JM, Roset M, Cucala M, Figueras M, Aliment Pharmacol Ther 2006 23 815 826 10.1111/j.1365-2036.2006.02828.x 16556184 (Pubitemid 43344601)
29. Co-morbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Vandevik PO, Wilhelmsen I, Ihlebäck C, Farup PG, Aliment Pharmacol Ther 2004 20 1195 1203 10.1111/j.1365-2036.2004. 02250.x 15569123 (Pubitemid 39657954)
30. Psychiatric, somatic and functional gastrointestinal disorders in patients with irritable bowel syndrome at a tertiary care center. Singh P, Agnihotri A, Pathak MK, Shirazi A, Tiwari RP, Sreenivas V, Sagar R, Makharia GK, J Neurogastroenterol Motil 2012 18 3 324 331 10.5056/jnm.2012.18.3.324 22837881
31. Development and validation of new disease-specific measures of somatisation and co-morbidity in IBS. Maclean EW, Palsson OS, Turner MJ, Whitehead WE, J Psychosom Res 2012 73 352 355
32. Somatic co-morbidities of irritable bowel syndrome: A systematic analysis. Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF, Mönnikes H, J Psychosom Res 2008 64 573 582 10.1016/j.jpsychores.2008.02. 021 18501257
33. Are anxiety and depression related to gastrointestinal symptoms in the general populations? Haug Tangen T, Mykletun A, Dahl A, Scand J Gastroenterol 2002 37 294 298 10.1080/003655202317284192 11916191 (Pubitemid 34194815)
34. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and non-patients with irritable bowel syndrome. Drossman DA, McKee DC, Sandler RS, Gastroenterology 1988 95 701 708 3396817
35. Psychological and psychiatric aspects of gastrointestinal disease. Olden KW, Drossman DA, Med Clin North Am 2000 84 1313 1327 10.1016/S0025-7125(05) 70288-1 11026930
36. Sleep disturbances in clinic patients with functional bowel disorders. Fass R, Fullerton S, Tung S, Mayer EA, Am J Gastroenterol 2000 95 1195 1200 10.1111/j.1572-0241.2000.02009.x 10811327 (Pubitemid 30263512)
37. Sleep disturbance influences gastrointestinal symptoms in women with irritable bowel syndrome. Jarett M, Heitkemper M, Cain KC, Burr RL, Hertig V, Dig Dis Sci 2000 45 952 959 10.1023/A:1005581226265 10795760 (Pubitemid 30238258)
38. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Lee S, Wu J, Ma L, Tsang A, Guo WJ, Sung J, Aliment Pharmacol Ther 2009 30 643 651 10.1111/j.1365-2036.2009.04074.x 19552631
39. Psychosocial factors at work and in everyday life are associated with irritable bowel syndrome. Faresjö Å Grodzinsky E, Johansson S, Wallander MA, Timpka T, Åkerlind I, Eur J Epidemiol 2007 22 7 473 480 10.1007/s10654-007-9133-2 17484023 (Pubitemid 47222952)
40. One-year prevalence of subthreshold and threshold DSM-IV. Generalized anxiety disorder in a nationally representative sample. Carter RM, Wittchen H, Pfister H, Kessler RC, Depress Anxiety 2001 13 78 88 10.1002/da.1020 11301924 (Pubitemid 32240185)
41. Serotonergic drugs in the treatment of depressive and anxiety disorders. Den Boer JA, Bosker FJ, Slaap BR, Hum Psychopharmacol 2000 15 315 336 10.1002/1099-1077(200007)15:5<315::AID-HUP204>3.0.CO;2-Y 12404310 (Pubitemid 30481102)
42. Serotonin: a review. Mohammad-Zadeh LF, Moses L, Gwaltney-Brant SM, J Vet Pharmocol Ther 2008 31 187 199 10.1111/j.1365-2885.2008.00944.x (Pubitemid 351677387)
43. Irritable bowel syndrome and migraine; bystanders or partners? Chang F, Lu CL, J Neurogastenterol Motil 2013 19 301 311 10.5056/jnm.2013.19.3.301
44. Nongastrointestinal disorders in the irritable bowel syndrome. Azpiroz F, Dapoigny M, Pace F, Müller-Lissner S, Coremans G, Whorwell P, Stockbrugger RW, Smout A, Digestion 2000 62 66 72 10.1159/000007780 10899728 (Pubitemid 30481292)
45. Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders. Guthrie EA, Creed FH, Whorwell PJ, Tomenson B, Gut 1992 33 361 363 10.1136/gut.33.3.361 1568655
46. Migraine and irritable bowel syndrome. Mulak A, Paradowski L, Neurol Neurochir Pol 2005 39 suppl 55 S60 16419571
47. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, Fich A, Buskila D, Am J Gatroenterol 1999 94 3541 3546 10.1111/j.1572-0241.1999.01643.x
48. Predictors for the course of chronic non-organic upper abdominal pain. Sloth H, Jörgensen LS, Scand J Gastroenterol 1989 24 440 444 10.3109/00365528909093072 2781239 (Pubitemid 19141430)
49. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA, BMC gastroenterol 2006 6 26 10.1186/1471-230X-6-26 17007634 (Pubitemid 44541885)
50. Joint involvement associated with inflammatory bowel disease. Vos DM, Dig Dis 2009 27 511 515 10.1159/000233290 19897967
51. Self-reported use of pharmaceuticals among patients with irritable bowel syndrome in primary care. Faresjö Å Grodzinsky E, Johansson S, Wallander MA, Faresjö T, Timpka T, JCMP 2008 14 9 870 877
52. Functional somatic syndromes: one or many? Wessely S, Nimnuan C, Sharpe M, Lancet 1999 354 936 939 10.1016/S0140-6736(98)08320-2 10489969 (Pubitemid 29424033)
53. Studying the overlap between IBS and GERD: a systematic review of the literature. Nastaskin I, Mehdikhani E, Conklin J, Park S, Pimentel M, Dig Dis Sci 2006 51 2113 2120 10.1007/s10620-006-9306-y 17080246
54. Gastrointestinal motility in patients with the irritable bowel syndrome. Abrahamsson H, Scand J Gastroenterol 1987 130 21 26 (Pubitemid 17112882)
55. Quality of life in inflammatory bowel disease in remisson: the impact of IBS-like symptom and associated psychological factors. Simrèn M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson ES, Am J Gastroenterol 2002 97 389 396 11866278 (Pubitemid 34160766)
56. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Bercik P, Verdu EF, Collins SM, Gastroenterol Clin North Am 2005 34 235 245 10.1016/j.gtc.2005.02.007 15862932 (Pubitemid 40615953)
57. Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases? Quigley EM, Chin J Dis 2005 6 122 132 10.1111/j.1443-9573.2005.00202.x (Pubitemid 41783309)
58. Swedish National Board of Health and Welfare, Patient register. The Hospital Discharge Register. Discharges 1964-2002, Quality and Content Stockholm: Swedish National Board of Health and Welfare 2004 21658213
59. Validation of diagnostic codes within medical services claims. Wilchesky M, Tamblyn RM, Huang A, J Clin Epidemiol 2004 57 131 141 10.1016/S0895-4356(03) 00246-4 15125622 (Pubitemid 38668607)
60. Validity of registration of ICD codes and prescriptions in a research database in Swedish primary care: a cross-sectional study in Skaraborg primary care database. Hjerpe P, Merlo J, Ohlsson H, Bengtsson Boström K, Lindblad U, BMC Med Inform Decis Mak 2010 10 23 10.1186/1472-6947-10-23 20416069
61. What do case-control studies estimate? Survey of methods and assumptions in published case-control research. Knol MJ, Vandenbroucke JP, Scott P, Egger M, Am J Epidemiol 2008 168 91073 91081
62. The general practitioner's approach to irritable bowel syndrome: From intention to practice. Bellini M, Tosetti C, Costa F, Biagi S, Stasi C, Del Punta A, Marchi S, Dig Liver Dis 2005 37 934 939 10.1016/j.dld.2005.06.011 16243592 (Pubitemid 44382347)
63. When to conduct testing in patients with suspected irritable bowel syndrome. Talley NJ, Rev Gastroenterol Dis 2003 3 suppl 18 24
64. Rome? Manning? Who care? Agreùs L, Am J Gastroenterol 2000 95 10 2679 2680 11051333
65. Using other people's data: the ins and outs of secondary data analysis. Arch GM III, Hueston WJ, Fam Med 1997 29 8 568 571 9310755 (Pubitemid 27410614)
66. The patient record in epidemiology. Kurland LT, Molgaard CA, Sci Am 1981 245 4 46 55 (Pubitemid 12227905)